Patents
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
06/2014
06/12/2014WO2014086284A1 Deuterated 3-cyano quinoline compound, pharmaceutical composition, preparation method and use thereof
06/12/2014WO2014062733A3 Substituted benzene compounds
06/12/2014WO2014047662A3 Indazole derivatives and uses thereof
06/12/2014US20140163231 Hepatitis C Virus Inhibitors
06/12/2014US20140163032 Ethers, secondary amines and derivatives thereof as modulators of the 5-ht 2a serotonin receptor useful for the treatment of disorders related thereto
06/12/2014US20140163016 Benzoxazines, benzothiazines, and related compounds having nos inhibitory activity
06/12/2014US20140163008 Dibenzooxepin derivative
06/12/2014US20140162997 Substituted pyrazoles as n-type calcium channel blockers
06/12/2014US20140162983 Compositions and Methods for the Production of Pyrimidine and Pyridine Compounds with BTK Inhibitory Activity
06/12/2014US20140162981 Substituted aryloxazoles and their use
06/12/2014US20140161845 Anti-biofilm compounds
06/11/2014EP2740730A1 Dibenzooxepin derivative
06/11/2014EP2739615A1 Phenyl-3-aza-bicyclo[3.1.0]hex-3-yl-methanones and the use thereof as medicament
06/11/2014CN103857670A 2-oxo-piperidinyl derivatives
06/11/2014CN103857668A Ethynyl derivatives as mglur5 allosteric modulators
06/11/2014CN103857661A 1,2,4-triazolyl-substituted keto-enols
06/11/2014CN103857659A Fused benzoxazepinones as ion channel modulators
06/11/2014CN103848828A Application of oxadiazole derivatives in anti-cancer drugs
06/11/2014CN103848827A Application of benzotriazole derivatives in anti-cancer drugs
06/11/2014CN103848826A Preparation method and use of 1,3,4-oxadiazole derivative having benzotriazole structure
06/11/2014CN103848821A Spiro compound serving as hepatitis C inhibitor, drug composition and applications of spiro compound and drug composition
06/11/2014CN103848818A Parallel ring compound serving as hepatitis C inhibitor, drug composition and applications of parallel ring compound and drug composition in drugs
06/11/2014CN103848814A Substituted indole ketone derivative as tyrosine kinase inhibitor
06/11/2014CN103848794A Synthesis method of isatoic anhydride and derivative thereof
06/11/2014CN102947289B Arylethynyl derivatives
06/11/2014CN102596936B Antiviral compounds
06/11/2014CN102267989B 2-methyl-benzofuran compounds and preparation and application thereof
06/11/2014CN102256963B Cyclic pyrimidin-4-carboxamides as ccr2 receptor antagonists for treatment of inflammation, asthma and copd
06/10/2014US8748634 Photochromic materials demonstrating improved fade rates
06/10/2014US8748627 Acetyl-CoA carboxylase (ACC) inhibitors and their use in diabetes, obesity and metabolic syndrome
06/10/2014US8748626 Oxazole and thiazole compounds as KSP inhibitors
06/10/2014US8748597 2,4-pyrimidinediamine compounds and their uses
06/10/2014US8748466 Isoxazole derivatives useful as antibacterial agents
06/10/2014US8748442 sGC stimulators
06/10/2014US8748440 Quinazolinone modulators of nuclear receptors
06/10/2014US8748431 Microbicidal heterocycles
06/10/2014US8748421 Triazine compounds as P13 kinase and MTOR inhibitors
06/10/2014US8748418 1,4-oxazepines as BACE1 and/or BACE2 inhibitors
06/10/2014US8748412 Phenylalanine derivatives and their use as non-peptide GLP-1 receptor modulators
06/10/2014US8748348 3-(3,4-dihydro-2H-benzo [1,4]oxazin-6-yl)-1H-pyrimidin-2,4-dione compounds as herbicides
06/10/2014CA2602474C Hydrogenated benzo (c) thiophene derivatives as immunomodulators
06/10/2014CA2541509C Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases
06/05/2014WO2014085225A1 Pyrimidine compounds for the treatment of cancer
06/05/2014WO2014084407A1 Dihydropyrone compounds and herbicides comprising the same
06/05/2014WO2014084330A1 Nitrogen-containing heterocyclic compound
06/05/2014WO2014082918A1 New indanyloxydihydrobenzofuranylacetic acids
06/05/2014WO2014082889A1 Novel imidazolines as dual inhibitors of mdm2 and mdmx
06/05/2014WO2014082379A1 Spiro ring compound as hepatitis c virus (hcv) inhibitor and uses thereof field of the invention
06/05/2014US20140155614 Pharmaceutical intermediates and process for the preparation thereof
06/05/2014US20140155607 Novel Salts of Raltegravir
06/05/2014US20140155596 Cysteinyl leukotriene antagonists
06/05/2014US20140155418 Receptor-Type Kinase Modulators and Methods of Use
06/05/2014US20140155408 Pyruvate kinase activators for use in therapy
06/05/2014US20140155402 Bi-heteroaryl compounds as vps34 inhibitors
06/05/2014US20140155401 Novel substituted bipyridine derivatives and their use as adenosine receptor ligands
06/05/2014US20140155396 C-Met Modulators and Method of Use
06/05/2014US20140155392 Methods of utilizing arylpiperazine derivatives
06/05/2014US20140155382 Anti-viral compounds
06/05/2014US20140155381 Compounds and methods
06/05/2014US20140155378 c-Met Modulators and Method of Use
06/05/2014US20140155377 3-cycloalkylaminopyrrolidine derivatives as modulators of chemokine receptors
06/04/2014EP2738169A1 Oxazolidinone compounds and their uses in preparation of antibiotics
06/04/2014EP2738168A1 N-hetero-ring-substituted amide derivative
06/04/2014EP2738167A2 Novel antithrombotic and antiatherosclerotic agent and method for producing same (variants)
06/04/2014EP2736904A1 Oxazole and thiazole derivatives as selective protein kinase inhibitors (c-kit)
06/04/2014EP2736897A1 Substituted picolinic acids and pyrimidine-4-carboxylic acids, method for the production thereof, and use thereof as herbicides and plant growth regulators
06/04/2014EP2736886A1 Substituted quinolines and their use as medicaments
06/04/2014EP2736883A1 Nuclear transport modulators and uses thereof
06/04/2014CN103842356A 1 - arylcarbonyl - 4 - oxy - piperidine compounds useful for the treatment of neurodegenerative diseases
06/04/2014CN103842346A Isoxazoline derivatives as insecticidal compounds
06/04/2014CN103842340A Nuclear transport modulators and uses thereof
06/04/2014CN103833744A 1-ethyl pyrazole acrylonitrile compound and application thereof
06/04/2014CN103833730A Benzo five-membered nitrogen-containing heterocycle-based piperazine derivative and preparation method as well as application thereof
06/04/2014CN103833663A Tridemorph quaternary ammonium base as well as preparation method and application thereof
06/04/2014CN103833658A Benzotriazole-based piperazine compound as well as preparation method and pharmaceutical composition thereof
06/04/2014CN103833643A Benzimidazolyl-piperazine compound and preparation method and pharmaceutical composition thereof
06/04/2014CN103833642A Application of benzo five-membered nitrogen-containing heterocycle-based piperazine derivative
06/04/2014CN103833544A 11-beta-hydroxysteroid dehydrogenase type i inhibitors
06/04/2014CN103831159A Azilsartan micronization method
06/04/2014CN102712624B Indole compound and pharmaceutical use thereof
06/04/2014CN102369187B N- (hetero)aryl, 2- (hetero)aryl-substituted acetamides for use as wnt signaling modulators
06/04/2014CN102083797B Tetrahydroisoquinolines, pharmaceutical compositions containing them, and their use in therapy
06/04/2014CN101861313B Phenyl amino pyrimidine compounds and uses thereof
06/03/2014US8742105 Polymorphs of raltegravir potassium
06/03/2014US8742100 Small molecule inhibitors of isoprenylcysteine carboxyl methyltransferase with potential anticancer activity
06/03/2014US8742099 Compounds
06/03/2014US8742098 Inhibitors of Bruton's tyrosine kinase
06/03/2014US8742097 Triazole compounds I
06/03/2014US8741942 Inhibitors of cellular necrosis
06/03/2014US8741932 Imidazopyridine derivatives
06/03/2014US8741923 Oxadiazole fused heterocyclic derivatives useful for the treatment of multiple sclerosis
06/03/2014US8741896 Pyrazolopyrimidine derivatives
06/03/2014US8741894 Arylsulfonamide CCR3 antagonists
06/03/2014US8741892 Compounds
06/03/2014US8741890 Substituted amides, manufacturing and use thereof as medicaments
06/03/2014US8741834 Dipeptoid prodrugs and the use thereof
06/03/2014CA2634198C N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase
06/03/2014CA2614981C Antibacterial quinoline derivatives
06/03/2014CA2590110C Kinase modulators and method of use
06/03/2014CA2563063C Purification of progesterone receptor modulators
1 ... 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 ... 647